Moderna sues Pfizer, BioNTech over COVID-19 MRNA technology patents


Last year, Pfizer’s Comirnaty brought it more than $36 billion in revenue worldwide. Analysts estimated that it could generate $33 billion this year, according to FactSet.

On the other hand, Modern generated $17.6 billion revenue from Spikevax. Analysts expected the company to achieve over $21 billion revenue from the vaccine this year.